高级检索

淋巴结跳跃转移对TxN>0M0分期原发性胸段食管鳞癌患者术后5年生存预测价值有限

Limited prognostic value of nodal skip metastasis for 5-year overall survival in patients with TxN>0M0 esophageal squamous cell carcinoma after radical surgery

  • 摘要: 目的:探讨淋巴结跳跃转移(nodal skip metastasis,NSM)对食管鳞癌患者根治术后5年总生存期(overall survival,OS)的预测价值,并比较美国癌症联合会(AJCC/UICC)淋巴结转移分期(按个数)与日本食管疾病学会(JSED)淋巴结转移分期(按站数)对患者术后生存的预测价值。方法:回顾性分析2007年1月至2010年12月接受食管癌根治性手术、术后病理确诊为原发性胸段食管鳞癌、有淋巴结转移且无其他部位转移(TxN>0M0)的356例患者的临床资料。356例患者中发生NSM 91例,占25.6%。采用log-rank生存分析及Cox多因素分析法分析影响患者术后5年OS的影响因素,并进行倾向性评分匹配(propensity score matching,PSM),评估NSM的预后意义。〖JP2〗采用Cox模型及一致性指数(index of concordance,C-index)比较AJCC/UICC指南N分期与JSED指南N分期对患者术后生存的预测能力。结果:高龄、肿瘤位置、术后T分期、术后N分期(AJCC/UICC分期和JSED分期)是患者术后5年OS的预测因素(均P<0.05),而NSM不是患者术后5年OS的预测因素。Cox生存预测模型中,采用AJCC/UICC指南N分期对患者术后生存的预测能力(C-index=0.632)优于JSED指南N分期(C-index=0.620),两者联合的预测能力更高(C-index=0.635)。结论:对于术后分期TxN>0M0的胸段食管鳞癌患者,NSM可能不是术后5年OS的预测因素;基于AJCC/UICC指南N分期的生存预测模型对患者预后的预测能力优于JSED指南N分期。

     

    Abstract: Objective:To identify the prognostic value of nodal skip metastasis (NSM) for 5-year overall survival (OS) in the patients with esophageal squamous cell carcinoma (ESCC) after radical surgery, and to compare the predictive value of lymph node metastasis staging by two different criteria (AJCC/UICC and JSED) for the survival of patients after operation. Methods:The clinical data of 356 patients with primary thoracic ESCC, lymph node metastasis, and no other metastasis (TxN>0M0) confirmed by postoperative pathology from January 2007 to December 2010 were retrospectively analyzed. NSM occurred in 25.6% (91 cases) of 356 patients. Log-rank survival analysis and Cox multivariate analysis were used to seek the influencing factors of postoperative 5-year OS in patients. Then the tendency score matching (PSM) was further performed to evaluate the prognostic significance of NSM. Cox model and C-index were used to compare the predictive value of AJCC/UICC guideline and JSED guideline N staging for the survival of patients. Results:Baseline variables including age, tumor location, postoperative T-stage, postoperative N-stage (AJCC/UICC and JSED) were predictors of postoperative 5-year OS, whereas NSM was not. According to the Cox survival prediction model constructed above, if using both AJCC/UICC and JSED standards as two independent N staging variables, the prediction ability of AJCC/UICC standard (C-index=0.632) was better than that of JSED standard (C-index=0.620), and the combined predictive value was best (C-index=0.635). Conclusions:For the ESCC patients with postoperative staging TxN>0M0, NSM has no significant correlation with 5-year OS. In addition, the survival prediction model based on AJCC/UICC N staging is superior to that JSED N staging in predicting prognosis of patient with TxN>0M0 esophageal squamous cell carcinoma.

     

/

返回文章
返回